The present invention relates to chemical compounds acting through GPR17 receptor for use in the treatment of diseases, in particular for use in chronic and/or acute neurodegenerative diseases, preferably Multiple Sclerosis, inflammatory diseases, pathologies involving the immune system, cardiovascular diseases, renal diseases.
GPR17 Receptor Modulators / M. Abbracchio, M. Battaglia, I. Eberini, M. Fumagalli, C. Parravicini, C. Sensi, P. Zaratin.
GPR17 Receptor Modulators
M. Abbracchio;I. Eberini;M. Fumagalli;C. Parravicini;C. Sensi;
2015
Abstract
The present invention relates to chemical compounds acting through GPR17 receptor for use in the treatment of diseases, in particular for use in chronic and/or acute neurodegenerative diseases, preferably Multiple Sclerosis, inflammatory diseases, pathologies involving the immune system, cardiovascular diseases, renal diseases.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
